- Hong Kong
- /
- Medical Equipment
- /
- SEHK:2393
Yestar Healthcare Holdings Full Year 2023 Earnings: CN¥0.005 loss per share (vs CN¥0.43 loss in FY 2022)
Yestar Healthcare Holdings (HKG:2393) Full Year 2023 Results
Key Financial Results
- Revenue: CN¥2.91b (down 32% from FY 2022).
- Net loss: CN¥11.1m (loss narrowed by 99% from FY 2022).
- CN¥0.005 loss per share (improved from CN¥0.43 loss in FY 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Yestar Healthcare Holdings shares are up 1.6% from a week ago.
Risk Analysis
It is worth noting though that we have found 4 warning signs for Yestar Healthcare Holdings (3 make us uncomfortable!) that you need to take into consideration.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SEHK:2393
Yestar Healthcare Holdings
An investment holding company, manufactures and sells medical imaging products in Mainland China.
Good value low.